Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRAME family member 29, pseudogene (PRAMEF29P) is a non-protein-coding member of the PRAME gene family in humans, classified as a pseudogene[1][3][5]. Unlike functional family members such as PRAME, which is a cancer-testis antigen involved in oncology and immunotherapy[2][6], PRAMEF29P does not encode an active protein and has no recognized biological or clinical function. It serves only as a genetic sequence, often used for evolutionary or genomic studies, without direct utility in diagnostics, therapy, or as a biomarker. For structured annotations: this target is mainly specified as a pseudogene, not a functional, druggable, or biologically active molecule. All entries related to drug interactions, mechanisms, disease roles, and biomarkers are null for PRAMEF29P, but relevant for other PRAME family members that are cancer/testis antigens and active in oncology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRAME family member 29, pseudogene (PRAMEF29P).